The crucial role of AhR in regulating GPR15 expression in CD4+ but not in CD8+ T cells suggests a potential therapeutic target in intestinal disorders, e.g., colorectal cancer where disruption of Gpr15 gene reduced infiltration of CD4+ Tregs but not CD8+ T cells into tumor sites and inhibited tumor growth (10). This evidence concerns the gene CD4 and neoplasm.